Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 21, 2021
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
Journal: Gastroenterology
Published: April 21, 2021
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.
Journal: Crohn's & colitis 360
Published: April 23, 2020
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
Journal: Cell host & microbe
Published: March 05, 2018
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 07, 2017
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: April 27, 2017
IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.
Journal: Science translational medicine
Published: May 16, 2016
Treatment of metastatic cutaneous Crohn disease with certolizumab.
Journal: Dermatology online journal
Published: November 16, 2015
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
Journal: Inflammatory bowel diseases
Published: October 02, 2015
Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
Journal: Journal of digestive diseases
Published: September 30, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026